CA-125 Change Over Time Shows Promise for Early Detection of Ovarian Cancer
Cancer Newsline
Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now show promise as a screening tool for early stage disease. Karen Lu, M.D., and Robert Bast, M.D., discuss their study highlighted at the year's American Society of Clinical Oncology (ASCO) conference.
Guest(s): Karen Lu, M.D.,
Robert Bast, M.D.